Glucotrack (GCTK) Change in Accured Expenses (2010 - 2025)

Glucotrack (GCTK) has 14 years of Change in Accured Expenses data on file, last reported at -$255000.0 in Q4 2025.

• Quarterly Change in Accured Expenses rose 42.95% year-over-year to -$255000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $17000.0 (up 104.04% YoY) and the FY2025 annual result came in at $17000.0, up 104.04% from the prior year.
• Change in Accured Expenses fell to -$255000.0 in Q4 2025, from $115000.0 in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $466000.0 in Q4 2023 to a low of -$447000.0 in Q4 2024.
• A 5-year average of -$5300.0 and a median of $5500.0 in 2022 frame the typical range for Change in Accured Expenses.
• Annual changes were most pronounced in 2023 — Change in Accured Expenses soared 435.63% — and 2024, when it plunged 1346.15%.
• Tracing GCTK's Change in Accured Expenses over 5 years: stood at -$30000.0 in 2021, then jumped by 390.0% to $87000.0 in 2022, then soared by 435.63% to $466000.0 in 2023, then slumped by 195.92% to -$447000.0 in 2024, then jumped by 42.95% to -$255000.0 in 2025.
• The last three Change in Accured Expenses figures came in at -$255000.0 (Q4 2025), $115000.0 (Q3 2025), and $106000.0 (Q2 2025), per Business Quant data.